Inscription Capital’s Cognizant CTSH Stock Holding History

Inscription Capital’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,024	Closed	-$370K	–	807
2026 Q1	$370K	Buy	6,024 +2,803	+87%	+$201K	0.04%	438
2025 Q4	$267K	Buy	+3,221	New	+$241K	0.03%	515

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Inscription Capital's CTSH Position: Q2 2026 in Review

Inscription Capital sold out of Cognizant (CTSH) in Q2 2026, closing a stake of 6,024 shares — an estimated $370K sold.

Inscription Capital first reported a position in CTSH in Q4 2025 and held it in 2 quarters. The position peaked at $370K in Q1 2026. 910 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

Inscription Capital reported no remaining Cognizant position as of Q2 2026 after selling out during the quarter.
Inscription Capital sold 6,024 Cognizant shares in Q2 2026, an estimated $370K.
Inscription Capital first reported a position in Cognizant in Q4 2025 and held it in 2 quarters.
Inscription Capital's Cognizant position peaked at $370K in Q1 2026.
910 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.